J.L. Bainbridge & Co’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-746
Closed -$44K 84
2022
Q1
$44K Sell
746
-699
-48% -$44.7K 0.01% 88
2021
Q4
$105K Sell
1,445
-235,146
-99% -$16.2M 0.01% 89
2021
Q3
$16.5M Sell
236,591
-4,309
-2% -$303K 1.97% 18
2021
Q2
$16.6M Sell
240,900
-13,812
-5% -$922K 1.98% 17
2021
Q1
$16.5M Buy
254,712
+6,352
+3% +$410K 2.17% 17
2020
Q4
$14.5M Sell
248,360
-15,924
-6% -$961K 2.04% 17
2020
Q3
$16.7M Sell
264,284
-4,718
-2% -$327K 2.65% 15
2020
Q2
$20.7M Buy
269,002
+3,945
+1% +$302K 3.76% 11
2020
Q1
$19.8M Buy
265,057
+18,092
+7% +$1.25M 3.77% 11
2019
Q4
$16M Sell
246,965
-39,289
-14% -$2.56M 2.23% 16
2019
Q3
$18.1M Sell
286,254
-3,831
-1% -$250K 2.71% 14
2019
Q2
$19.6M Sell
290,085
-6,498
-2% -$427K 2.97% 14
2019
Q1
$20.1M Buy
296,583
+9,364
+3% +$622K 2.95% 14
2018
Q4
$18M Sell
287,219
-5,621
-2% -$393K 3.13% 13
2018
Q3
$22.6M Sell
292,840
-1,729
-0.6% -$131K 3.08% 14
2018
Q2
$20.9M Buy
+294,569
New +$20.8M 3.1% 15

Other funds holding GILD

J.L. Bainbridge & Co's GILD Position: Q2 2022 in Review

J.L. Bainbridge & Co sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 746 shares — an estimated $44K sold.

J.L. Bainbridge & Co first reported a position in GILD in Q2 2018 and held it in 16 quarters. The position peaked at $22.6M in Q3 2018. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • J.L. Bainbridge & Co reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • J.L. Bainbridge & Co sold 746 Gilead Sciences shares in Q2 2022, an estimated $44K.
  • J.L. Bainbridge & Co first reported a position in Gilead Sciences in Q2 2018 and held it in 16 quarters.
  • J.L. Bainbridge & Co's Gilead Sciences position peaked at $22.6M in Q3 2018.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on J.L. Bainbridge & Co's 13F filing for Q2 2022, filed 4 Aug 2022.